Tau is also strongly implicated in the synaptic defects in Alzheimer’s disease with positive correlations between the extent of tau pathology, cognitive impairment and glutamatergic synapse loss observed both post-mortem17-21 and recently in vivo. The gene discussed is MAPT; the disease is Alzheimer disease.